Modification of Tumor Cells with Fas (CD95) Antigen Gene and Fas Ligand (CD95L) Gene Transfection by Electroporation for Immunotherapy of Cancer

By Shimizu Motomu   Yoshimoto Takayuki   Matsuzawa Akio   Takeda Yasutaka  

Molecular Biotechnology, Vol. 25, Iss. 1, 2003-09 ,pp. : 79-88

Humana Press, Inc

Access to resources Recommend Favorite

Expression and Characterization of Biologically Active Human Fas Ligand Produced in CHO Cells

By Zappitelli Sabrina   D’Alatri Laura   Ciucci Alessandra   Raucci Giuseppe   Faiella Angela   Gabrielli Meri   Parlani Massimo   Bressan Alessandro   Maggi Carlo A.   Goso Cristina   Rotondaro Luigi  

Molecular Biotechnology, Vol. 23, Iss. 3, 2003-05 ,pp. : 189-202

Humana Press, Inc

Access to resources Recommend Favorite

Efficient expression and primary purification of 6-his tagged human Fas ligand in Dictyostelium discoideum

By Chen Jie   Lu Yinghua   Xu Zhinan   Cen Peilin   Fang Xiangming  

Biotechnology Letters, Vol. 29, Iss. 6, 2007-06 ,pp. : 859-863

Springer Publishing Company

Access to resources Recommend Favorite

Suppression of Fas-mediated hepatic apoptosis by caspase inhibitor-encapsulated nanoparticles bearing poly-(N-p-vinylbenzyl-O-β-D-galactopyranosyl-[1-4]-D-gluconamide)

By Shibuya I.  

Biotechnology Letters, Vol. 22, Iss. 23, 2000-12 ,pp. : 1855-1859

Springer Publishing Company

Access to resources Recommend Favorite

An oligosaccharide fraction from Korean mugwort herb suppresses death of the mouse thymocytes in culture by down-regulating the Fas death receptor gene

By Kyung Chung H.  

Biotechnology Letters, Vol. 25, Iss. 18, 2003-09 ,pp. : 1549-1553

Springer Publishing Company

Access to resources Recommend Favorite